Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Lattimore Rd
Ste 258
Rochester, NY 14620Phone+1 585-442-8020Fax+1 585-442-8039
Summary
- I am Board Certified in Gynecologic Oncology and Obstetrics and Gynecology. I am a Fellow of the ACOG and a Fellow American College of Surgeons
Education & Training
- Women and Infants Hospital of Rhode Island/Brown UniversityFellowship, Gynecologic Oncology, 1999 - 2002
- Eastern Virginia Medical SchoolResidency, Obstetrics and Gynecology, 1993 - 1997
- University of AlbertaClass of 1993
Certifications & Licensure
- NY State Medical License 2015 - 2026
- MA State Medical License 2001 - 2016
- RI State Medical License 1999 - 2016
- CT State Medical License 2002 - 2015
- NC State Medical License 1997 - 2003
- VA State Medical License 1996 - 2002
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Ovarian Cancer Risk Estimation in Patients With Pelvic Mass Start of enrollment: 2009 Oct 01
- Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass. Start of enrollment: 2016 Jun 30
- EP0057 in Combination With Olaparib in Advanced Ovarian Cancer Start of enrollment: 2020 Dec 14
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsCediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-...Jung-Min Lee, Mark F Brady, Austin Miller, Richard G Moore, Helen MacKay
Journal of Clinical Oncology. 2024-12-20 - First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.Christian Marth, Richard G Moore, Mariusz Bidziński, Sandro Pignata, Ali Ayhan
Journal of Clinical Oncology. 2024-11-26 - Identification of circulating tumor cells captured by the FDA-cleared ParsortixPC1 system from the peripheral blood of metastatic breast cancer patients using immunofl...Mariacristina Ciccioli, Kyukwang Kim, Negar Khazan, Joseph D Khoury, Martin J Cooke
Journal of Experimental & Clinical Cancer Research. 2024-08-21
Press Mentions
- Targeted Treatment for Ovarian Cancer DiscoveredFebruary 19th, 2014
- FDA Clears Biomarker Test for Ovarian CancerSeptember 6th, 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: